Corporate Finance

Pharma Distribution M&A Opportunity

Despite of their apparent large sizes, many of the CACA countries are not very densely populated and are relatively new to market economics, which leaves them very vulnerable to ‘the giants’ lurking around- whether in the form of China & India, or Russia & Turkey, but also EU, S.Korea, Japan…

This begs the question whether they can compete in any industry, but even more so in giant-company dominated pharmaceuticals market!? Well, as it turns out some of the negative exogenous influences on the local players, turn out as advantages when thinking of foreign competition & barriers to entry:

  • existing market prices are often not attractive enough for setting up shop
  • government initiatives & regulation seem too burdensome from far
  • licensing for small volumes & targeted production is overwhelming
  • long-term state, hospital & doctor rolodexes the locals have are golden
  • reliability of the local brand & pharmacist is not substitutable
  • there is a touch of xenophobia as well, worried that ‘their’ sheer numbers will overrun the country in question
  • knowledge of the local personnel, education & training markets is an edge
  • own distribution and logistics is strengthening local producers
  • own local ‘generic-brands’ are known while a no-name imported generic is not
  • mid-segment is the key hunting ground for many a locals, by adding a little margin to the locally known product / brand

As one can imagine it is not easy finding consistent, reliable & up-to-date data on one EMMA country alone, let alone on a whole region like CACA which is not always known for its transparency. So when we found a source that collected & sorted some statistics for 11 countries we imagine the CACA region, we jumped on it regardless how old or potentially erroneous… No wonder, it was published by the International federation of pharmaceutical manufacturers & associations (IFPMA, 2017):

While the data can be informative in many ways, we wanted to rank the countries for a select representative category indicators that were reported. In terms of Life expectancy at birth (yrs), Physicians (per 1,000), Health expenditure ($ per capita) and Pharma sales ($ per capita), the ranking was as follows (from most developed to least): Georgia, Kazakhstan, Azerbaijan, Iran, Mongolia, Armenia, Uzbekistan, Kyrgyzstan, Turkmenistan, Tajikistan, Afghanistan. Note that some of the countries may be quite closed to the rest of the world & their data does not best reflect the reality, while others may have inherited better infrastructure & public health standards.

With that in mind, we present a case study for an interesting ‘consolidation cross-border play opportunity’ spanning the CACA region (or even wider)

  • A thesis that would under current market access include country pharma leaders in Kyrgyzstan & Mongolia, as well as one of top players in Uzbekistan & Armenia each

To a reader it may seem that we are mimicking Chingiz Aitmatov’s “Tales of the Mountains and Steppes” given the main choice of the countries, but it is in the middle that the democratic or market processes are relatively advanced, and where potentially best or easiest CACA pharma opportunities lie…

If you have a genuine wish to discuss potential Pharma Distribution M&A Opportunity – please do write us, and we will send you the password to the next section of the pharma theme- which introduces 4 markets & companies along with the experts involved:

Contact Us  to   Read More

 

Theme Related Tracker

Some monitored stuff:

Pharmaceutical expenditure (OECD)

 

  

Video: With funding from the European Union, the EBRD worked with ABC Pharmacia, one of the main suppliers of pharmaceuticals in Georgia … 

go2em

  • Reality of U.S. Mediation and the Fragile South Asian Ceasefire
    on May 15, 2025

    In a significant development, India’s Ministry of External Affairs confirmed that a ceasefire agreement between India and Pakistan came into effect on May 10 following direct talks between the two countries’ military leaderships. At 15:35 IST, Pakistan’s Director General of Military […]

  • Do Not Misjudge the U.S.-China Geneva Joint Statement
    on May 14, 2025

    At 3 p.m. Beijing time on 12 May, China and the U.S. simultaneously released a Joint Statement on U.S.-China Economic and Trade Meeting in Geneva. The sides agreed to roll back all tariff hikes imposed since April 8 by May 14. The U.S. committed to halt the initial 24% duties introduced on April 2 […]

  • The West Is Dismantling the Foundations of 1945
    on May 12, 2025

    Eighty years is a long time. Over such a span, the world changes almost beyond recognition, and events that once felt close fade into legend. Yet while history may become distant, its imprint remains. The Second World War created a political order that shaped global affairs for decades – an order […]

  • Two Similar, But Quite Different, Victory Narratives: Britain and the USSR
    on May 9, 2025

    Russians waiting for The Voice finale this April might have seen the First Channel’s special news report beforehand: what do foreign school history textbooks say about the USSR’s role in the war? The report, which mostly focused on British, French and German textbooks, was like Christmas for […]

  • Four WWII Myths: Ignoring China, Downplaying Russia
    on May 9, 2025

    With the approach the 80th anniversary of the end of World War II, it has become increasingly visible how China and Russia’s vital roles in defeating fascism are downgraded and distorted in the Western narrative. The West’s selective memory misleads public perception of the past and confuses […]

  • Forget Land – This Is Russia’s Main Demand From the West
    on May 5, 2025

    Everyone is expecting news on a Ukrainian settlement this week. The diplomatic activity is real and intense, and the visible signs suggest something significant is underway. There is little point in trying to guess which of the leaked plans are genuine and which are misinformation. What is clear is […]